Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4648264
Max Phase: Preclinical
Molecular Formula: C24H27ClN6O3S2
Molecular Weight: 547.11
Molecule Type: Unknown
Associated Items:
ID: ALA4648264
Max Phase: Preclinical
Molecular Formula: C24H27ClN6O3S2
Molecular Weight: 547.11
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@@H]1CCCN1Cc1sc(NC(=O)c2cnc(N3CCC(C(=O)O)CC3)nc2)nc1-c1cc(Cl)cs1
Standard InChI: InChI=1S/C24H27ClN6O3S2/c1-14-3-2-6-31(14)12-19-20(18-9-17(25)13-35-18)28-24(36-19)29-21(32)16-10-26-23(27-11-16)30-7-4-15(5-8-30)22(33)34/h9-11,13-15H,2-8,12H2,1H3,(H,33,34)(H,28,29,32)/t14-/m1/s1
Standard InChI Key: VVMLIGYQDSDWNH-CQSZACIVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 547.11 | Molecular Weight (Monoisotopic): 546.1275 | AlogP: 4.85 | #Rotatable Bonds: 7 |
Polar Surface Area: 111.55 | Molecular Species: ACID | HBA: 9 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.40 | CX Basic pKa: 7.94 | CX LogP: 1.92 | CX LogD: 1.84 |
Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.43 | Np Likeness Score: -1.77 |
1. Tanaka H, Negoro K, Koike T, Tsukamoto I, Yokoyama K, Maeda J, Inagaki Y, Shimoshige Y, Ino K, Ishizu K, Takahashi T.. (2020) Discovery and structure-activity relationships study of positive allosteric modulators of the M3 muscarinic acetylcholine receptor., 28 (13): [PMID:32386953] [10.1016/j.bmc.2020.115531] |
Source(1):